Pyoderma Gangrenosum Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is pyoderma gangrenosum (PG)?

A

A rare, non-infectious, neutrophilic dermatosis characterized by painful, rapidly progressive ulceration with undermined borders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the hallmark feature of PG?

A

Painful ulcers with violaceous, undermined edges and purulent bases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Who is most commonly affected by pyoderma gangrenosum?

A

Adults aged 20–50 years, with a slight female predominance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the underlying cause of PG?

A

The exact cause is unknown, but it involves dysregulation of the immune system, specifically neutrophil dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What systemic diseases are commonly associated with PG?

A

Inflammatory bowel disease (Crohn’s disease, ulcerative colitis).

Rheumatologic conditions (e.g., rheumatoid arthritis, seronegative arthritis).

Hematologic diseases (e.g., myelodysplastic syndrome, leukemia).

Monoclonal gammopathies (e.g., IgA gammopathy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What triggers can precipitate PG?

A

Trauma or surgery (pathergy phenomenon).

Stress.

Infection or injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the pathophysiologic mechanism in PG?

A

Dysregulated immune response with excessive neutrophil infiltration, leading to tissue destruction and ulceration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the characteristic features of pyoderma gangrenosum ulcers?

A

Painful, rapidly enlarging ulcers.

Undermined, violaceous borders.

Purulent or necrotic bases with granulation tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the most common site of PG lesions?

A

Lower extremities, particularly the anterior tibia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the subtypes of pyoderma gangrenosum?

A

Ulcerative PG: Classic form with deep ulcers.

Bullous PG: Associated with hematologic malignancies, presents with superficial vesicles or bullae.

Pustular PG: Small pustules, often associated with inflammatory bowel disease.

Vegetative PG: A milder, less aggressive form with superficial, non-painful ulcers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is pyoderma gangrenosum diagnosed?

A

Clinical diagnosis based on characteristic ulcers and exclusion of other causes.

No definitive test; relies on history, examination, and biopsy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are key histological features of PG?

A

Dermal neutrophilic infiltrate without vasculitis.

Ulceration and necrosis.

Exclusion of infection or malignancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is it important to rule out infection in PG?

A

Treatment involves immunosuppression, which can worsen an underlying infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the goals of treatment in PG?

A

Reduce inflammation, promote ulcer healing, and manage underlying conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the first-line treatment for PG?

A

Systemic corticosteroids (e.g., prednisone) or cyclosporine to suppress the immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What other systemic immunosuppressants are used in PG?

A

Azathioprine.

Mycophenolate mofetil.

Methotrexate.

Cyclophosphamide (severe cases).

17
Q

What biologic therapies are effective for refractory PG?

A

TNF-α inhibitors (e.g., infliximab, adalimumab).

IL-1 inhibitors (e.g., anakinra).

18
Q

How are mild cases of PG managed?

A

Topical or intralesional corticosteroids.

Calcineurin inhibitors (e.g., tacrolimus).

19
Q

What supportive treatments are important in PG?

A

Wound care to prevent secondary infections.

Pain management.

Compression therapy for lower extremity lesions if there is no contraindication.

20
Q

What is the risk of recurrence in PG?

A

High; up to 30–50% of patients experience relapses.

21
Q

What factors indicate a poor prognosis in PG?

A

Delayed diagnosis, underlying hematologic malignancy, and widespread disease.

22
Q
A